Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy

Overview of attention for article published in Blood, October 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 89 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 31,101 followers.

@Cyn9383Johnson @mcfunny @KStateTurk @MsTrixter @swedishchf @StahpL @InsideVaccines @handmadekathy @StopCensorship7 @Just4TheCause @KatLaRue7 @MLAnder87321751 @RisetteMD @fuiwontdowhatu1 @AndrewLazarus4 @doritmi @provaxtexan @_mamadeb @JestrBob @Bucklyn…

Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy https://t.co/tZmStpKufs

RT @Myeloma_Doc: Intravenous immune globulin increases risk of thromboembolic events in CLL & #myeloma pts by only 0.3-0.7%: http://t.co/Md…

Intravenous immune globulin increases risk of thromboembolic events in CLL & #myeloma pts by only 0.3-0.7%: http://t.co/MdVjnrdXTD.

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.